Stockscreener 앱 받기
0.5472
6.78%
-0.0398
전일 마감가:
$0.587
열려 있는:
$0.5914
하루 거래량:
1.47M
Relative Volume:
0.14
시가총액:
$15.68M
수익:
-
순이익/손실:
$-11.38M
주가수익비율:
-0.0197
EPS:
-27.73
순현금흐름:
$-12.72M
1주 성능:
-8.82%
1개월 성능:
-30.34%
6개월 성능:
+366.10%
1년 성능:
-94.89%
1일 변동 폭
$0.5376
$0.5914
1주일 범위
$0.502
$0.6527
52주 변동 폭
$0.0915
$13.27
Windtree Therapeutics Inc Stock (WINT) Company Profile
명칭
Windtree Therapeutics Inc
전화
(215) 488-9300
주소
2600 KELLY ROAD, WARRINGTON, PA
WINT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WINT
Windtree Therapeutics Inc
|
0.5472 | 6.68M | 0 | -11.38M | -12.72M | -27.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Windtree Therapeutics Inc Stock (WINT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-26 | 개시 | Ladenburg Thalmann | Buy |
Windtree Therapeutics Inc 주식(WINT)의 최신 뉴스
Windtree Advances Istaroxime Toward Global Phase 3 Following Positive Interim Study Results - MSN
Institutional Tools Highlight Unusual Flow in Windtree Therapeutics Inc.Stable Entry High Return Opportunities in Focus - beatles.ru
Windtree Therapeutics' Strategic Shift in Clinical Development and Its Implications for Istaroxime's Future - AInvest
Windtree Therapeutics Terminates SEISMiC-C Clinical Study - TipRanks
Windtree Therapeutics Announces Promising Phase 2 Study Results for Istaroxime - MSN
Windtree Therapeutics to acquire Titan Environmental Services - MSN
Windtree Therapeutics Incannounces interim analysis of istaroxime Phase 2 Study - MarketScreener
Windtree Therapeutics Reveals Promising Phase 2 Study Data - TipRanks
Windtree Therapeutics, Inc. Reports Positive Interim Analysis for Istaroxime in Phase 2 Study of Cardiogenic Shock - Quiver Quantitative
Breakthrough Clinical Data: Istaroxime Phase 2 Trial Advances Heart Failure Treatment to Phase 3 - Stock Titan
Windtree Therapeutics Appoints New Audit Committee Chair - TipRanks
WINT 8-K: Audit Chair Resigns, New Independent Director Appointed | NJR SEC FilingForm 8-K - Stock Titan
WINT 8-K: Audit Chair Changes Hands; Andrew Kucharchuk Joins Board | WINT SEC FilingForm 8-K - Stock Titan
BNB gaining mainstream acceptance, with companies like Nano Labs and Windtree Therapeutics allocating it to their treasuries. - AInvest
Windtree Therapeutics Stock Soars 10.5% on R&D Progress - AInvest
What are analysts’ price targets for Windtree Therapeutics Inc. in the next 12 monthsReal-time trading signals for maximum returns - Jammu Links News
How does Windtree Therapeutics Inc. generate profit in a changing economyInvest smarter with daily market updates - Jammu Links News
Is it the right time to buy Windtree Therapeutics Inc. stockConsistent wealth multiplication - Jammu Links News
How volatile is Windtree Therapeutics Inc. stock compared to the marketFree Smart Trading Workshop - Jammu Links News
When is Windtree Therapeutics Inc. stock expected to show significant growthAchieve remarkable returns with smart investing - Jammu Links News
What is the dividend policy of Windtree Therapeutics Inc. stockBuild a diversified portfolio for risk management - Jammu Links News
Windtree Therapeutics Inc. Stock Analysis and ForecastDiscover undervalued stocks before they soar - Jammu Links News
What catalysts could drive Windtree Therapeutics Inc. stock higher in 2025Accelerate your capital gains today - Jammu Links News
How does Windtree Therapeutics Inc. compare to its industry peersConsistently high returns - jammulinksnews.com
Windtree Therapeutics Cuts Preferred Stock by Over 99% Ahead of Crypto Strategy Rollout - MSN
Sentiment Turns Positive on Windtree Therapeutics Inc. — Reversal AheadAI Powered High Return Stock Calls Dominate Watchlists - metal.it
MACD Cross Could Confirm Trend in Windtree Therapeutics Inc.Confirmed Setup With Expert Accuracy Supported - beatles.ru
Will wint go up tomorrow? - AInvest
Windtree Therapeutics Secures $520 Million in Equity Agreements to Expand BNB Cryptocurrency Holdings - MSN
What makes Windtree Therapeutics Inc. stock price move sharplyAccurate Buy Point for Momentum Stocks Detected - beatles.ru
RSI Reset May Fuel Rebound in Windtree Therapeutics Inc.Weekly Return Pick Forecast Reports Show Trend - metal.it
How Interest Rate Changes Impact Windtree Therapeutics Inc. Stock PerformanceChart-Based Trade Entries Gain Analyst Support - metal.it
Bitcoin News Today: Windtree Therapeutics Secures $520 Million to Expand BNB Treasury Strategy to $700 Million - AInvest
Why Windtree Therapeutics Inc. stock attracts strong analyst attentionWeekly Top Gainers Forecast Watchlist Released - beatles.ru
Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption - The Manila Times
Windtree Therapeutics Announces Significant Redemption and Conversion of Preferred Shares, BNB Coin Value Increases Following Crypto Treasury Agreement - Quiver Quantitative
Windtree Eliminates 99% of Preferred C Shares as BNB Crypto Strategy Sees 17% Gain - Stock Titan
Windtree Therapeutics Inc. Sees Spike in Bullish Option FlowLow Capital High Return Stock Plans Reviewed - metal.it
Screener Results Flag Windtree Therapeutics Inc. as OversoldAI Driven Stock Trend Forecast Shows Momentum Shift - beatles.ru
Will Windtree Therapeutics Inc. stock benefit from AI tech trendsDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Should I hold or sell Windtree Therapeutics Inc. stock in 2025Consistently superior profits - Jammu Links News
Windtree Taps Kraken to Power BNB Crypto Treasury Strategy - MSN
What institutional investors are buying Windtree Therapeutics Inc. stockBuild a winning portfolio with smart picks - jammulinksnews.com
Sectors Driving Future Growth for Windtree Therapeutics Inc. StockSolid Return Trade Selections - metal.it
Windtree Therapeutics Secures $520M to Expand BNB Reserves in Strategic Pivot to Blockchain-Based Assets - AInvest
Windtree Therapeutics Inc (WINT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):